Low activated leukocyte cell adhesion molecule expression is associated with advanced tumor stage and early prostate-specific antigen relapse in prostate cancer

Human Pathology

Volumn 42, Issue 12, 2011, Pages 1946-1952

  Minner, Sarah ^a   Kraetzig, Franziska ^a   Tachezy, Michael ^a   Kilic, Ergin ^a   Graefen, Markus ^b   Wilczak, Waldemar ^a   Bokemeyer, Carsten ^a   Huland, Hartwig ^b   Sauter, Guido ^a   Schlomm, Thorsten ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Laboratory of Radiobiology and oExperimental Radiooncology   (Germany)

Author keywords

ALCAM; CD166; Prognosis; Prostate cancer; Tissue microarray (TMA)

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CELL FUNCTION; CONTROLLED STUDY; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PROSTATE CANCER; PROSTATECTOMY; PROTEIN LOCALIZATION; TISSUE MICROARRAY;

AGED; ANTIGENS, CD; CELL ADHESION MOLECULES, NEURONAL; FETAL PROTEINS; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM STAGING; ODDS RATIO; PHENOTYPE; PROGNOSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SURVIVAL ANALYSIS; TISSUE ARRAY ANALYSIS;

EID: 80955133890     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2011.02.017     Document Type: Article

References (25)

1. O. Ohneda, K. Ohneda, and F. Arai ALCAM (CD166): its role in hematopoietic and endothelial development Blood 98 2001 2134 2142
2. A. Masedunskas, J.A. King, and F. Tan Activated leukocyte cell adhesion molecule is a component of the endothelial junction involved in transendothelial monocyte migration FEBS Lett 580 2006 2637 2645
3. L.C. van Kempen, J.J. van den Oord, and G.N. van Muijen Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin Am J Pathol 156 2000 769 774 (Pubitemid 30626933)
4. W.G. Degen, L.C. van Kempen, and E.G. Gijzen MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule) Am J Pathol 152 1998 805 813 (Pubitemid 28110727)
5. J.A. King, S.F. Ofori-Acquah, and T. Stevens Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator Breast Cancer Res 6 2004 R478 R487
6. M. Burkhardt, E. Mayordomo, and K.J. Winzer Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer J Clin Pathol 59 2006 403 409
7. W. Weichert, T. Knosel, and J. Bellach ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival J Clin Pathol 57 2004 1160 1164 (Pubitemid 39486521)
8. B.B. Patel, Y. Yu, and J. Du Age-related increase in colorectal cancer stem cells in macroscopically normal mucosa of patients with adenomas: a risk factor for colon cancer Biochem Biophys Res Commun 378 2009 344 347
9. A. Verma, N.K. Shukla, and S.V. Deo MEMD/ALCAM: a potential marker for tumor invasion and nodal metastasis in esophageal squamous cell carcinoma Oncology 68 2005 462 470 (Pubitemid 41160978)
10. C. Kahlert, H. Weber, and C. Mogler Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse Br J Cancer 101 2009 457 464
11. M. Sawhney, A. Matta, and M.A. Macha Cytoplasmic accumulation of activated leukocyte cell adhesion molecule is a predictor of disease progression and reduced survival in oral cancer patients Int J Cancer 124 2009 2098 2105
12. D. Mezzanzanica, M. Fabbi, and M. Bagnoli Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients Clin Cancer Res 14 2008 1726 1733 (Pubitemid 351469457)
13. M.V. Corrias, C. Gambini, and A. Gregorio Different subcellular localization of ALCAM molecules in neuroblastoma: association with relapse Cell Oncol 32 2010 77 86
14. A.Y. Liu, M.P. Roudier, and L.D. True Heterogeneity in primary and metastatic prostate cancer as defined by cell surface CD profile Am J Pathol 165 2004 1543 1556 (Pubitemid 39435154)
15. K. Tomita, A. van Bokhoven, and C.F. Jansen Coordinate recruitment of E-cadherin and ALCAM to cell-cell contacts by alpha-catenin Biochem Biophys Res Commun 267 2000 870 874 (Pubitemid 30099415)
16. G. Kristiansen, C. Pilarsky, and C. Wissmann ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions Prostate 54 2003 34 43 (Pubitemid 36043834)
17. G. Kristiansen, C. Pilarsky, and C. Wissmann Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival J Pathol 205 2005 359 376 (Pubitemid 40253926)
18. B. Liu, F. Conrad, and A. Roth Recombinant full-length human IgG1s targeting hormone-refractory prostate cancer J Mol Med 85 2007 1113 1123 (Pubitemid 47476727)
19. A. Roth, D.C. Drummond, and F. Conrad Anti-CD166 single chain antibody-mediated intracellular delivery of liposomal drugs to prostate cancer cells Mol Cancer Ther 6 2007 2737 2746 (Pubitemid 350058154)
20. A. Erbersdobler, H. Fritz, and S. Schnoger Tumour grade, proliferation, apoptosis, microvessel density, p53, and bcl-2 in prostate cancers: differences between tumours located in the transition zone and in the peripheral zone Eur Urol 41 2002 40 46 (Pubitemid 34760124)
21. L. Bubendorf, J. Kononen, and P. Koivisto Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays Cancer Res 59 1999 803 806 (Pubitemid 29086730)
22. T. Schlomm, L. Iwers, and P. Kirstein Clinical significance of p53 alterations in surgically treated prostate cancers Mod Pathol 21 2008 1371 1378
23. M. van den Brand, R.P. Takes, and M. Blokpoel-deRuyter Activated leukocyte cell adhesion molecule expression predicts lymph node metastasis in oral squamous cell carcinoma Oral Oncol 46 2010 393 398
24. K. Uhlenbrock, A. Eberth, and U. Herbrand The RacGEF Tiam1 inhibits migration and invasion of metastatic melanoma via a novel adhesive mechanism J Cell Sci 117 2004 4863 4871 (Pubitemid 39433450)
25. L.C. van Kempen, F. Meier, and M. Egeblad Truncation of activated leukocyte cell adhesion molecule: a gateway to melanoma metastasis J Invest Dermatol 122 2004 1293 1301 (Pubitemid 38651106)